Skip to content

EV / sales at other companies

Abbott logo
AbbottABT
4.6×-1.0×
DexCom logo
DexComDXCM
4.8×-1.5×
Medtronic logo
MedtronicMDT
3.6×-0.4×
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
1.8×+0.1×
Embecta Corp. logo
Embecta Corp.EMBC
1.6×-0.3×
Owlet logo
OwletOWLT
1.3×+0.5×

Other financials

Income statement

See full
Revenue$11.7M+87.2%
Gross profit$6.9M+361%
Operating income-$31.8M-136%
Net income-$32.3M-127%
EPS (diluted)-$0.71-77.5%

Balance sheet

See full
Cash & equivalents$29.6M-24.7%
Total debt$43.1M+5.0%
Total equity$34.3M-2.4%
Total assets$102.9M+17.9%

Cash flow

See full
Operating cash flow-$32.0M-99.2%
CapEx$111.0K-74.4%
Free cash flow-$32.1M-94.6%

Valuation

See full
Market cap$296.51M-21.4%
Enterprise value$310.04M-19.9%
P/S7.3×-7.5×

Profitability

See full
Gross margin52.1%+44.9pp
Operating margin-213%-46.7pp
Net margin-214.1%-51.2pp
FCF margin-186.4%-37.0pp

Returns & leverage

See full
Return on equity-250.7%-19.0pp
Debt / equity1.3×+0.1×
Current ratio3.5×-3.4×

Where this comes from

Calculated from Senseonics Holdings, Inc. ’s reported figures.

Based on the most recent quarter.

The official record: Senseonics Holdings, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Senseonics Holdings, Inc. 's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Senseonics Holdings, Inc. 's EV / sales?
Senseonics Holdings, Inc. (SENS) reported EV / sales of 7.2× in Q1 2026.
How has Senseonics Holdings, Inc. 's EV / sales changed year-over-year?
Senseonics Holdings, Inc. 's EV / sales decreased by 60.5% year-over-year, from 18.1× to 7.2×.
What is the long-term trend for Senseonics Holdings, Inc. 's EV / sales?
Over 5 years (2020 to 2025), Senseonics Holdings, Inc. 's EV / sales has grown at a -38.4% compound annual growth rate (CAGR), from 72.6× to 6.4×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.